论文部分内容阅读
目的探讨新辅助化疗联合腹腔镜下广泛全子宫切除、盆腔淋巴结清扫治疗局部晚期宫颈癌的临床疗效。方法局部晚期宫颈癌患者76例,根据治疗方法分为腹腔镜组和开腹组。腹腔镜组40例新辅助化疗后行腹腔镜下广泛全子宫切除+盆腔淋巴结清扫术+腹主动脉淋巴结清扫术;开腹组36例新辅助化疗后给予经腹广泛子宫切除术+盆腔淋巴结清扫术+腹主动脉淋巴结清扫术。结果新辅助化疗的总有效率为89.47%。两组年龄、分期、病理分级无统计学差异(P>0.05)。腹腔镜组术中出血量、下床活动时间、肛门排气时间、住院时间均少于开腹组,两组比较,差异有统计学意义(P<0.05);两组淋巴结清扫数量、手术时间、切口感染率比较,差异无统计学意义(P>0.05)。结论新辅助化疗联合腹腔镜下广泛子宫切除术治疗局部晚期宫颈癌疗效满意,安全可行。
Objective To investigate the clinical effect of neoadjuvant chemotherapy combined with laparoscopic radical hysterectomy and pelvic lymph node dissection in the treatment of locally advanced cervical cancer. Methods 76 patients with locally advanced cervical cancer were divided into laparoscopic group and laparotomy group according to the method of treatment. Laparoscopic group of 40 cases of neoadjuvant chemotherapy after laparoscopic radical hysterectomy + pelvic lymph node dissection + abdominal aortic lymph node dissection; open group of 36 cases of neoadjuvant chemotherapy after radical abdominal hysterectomy + pelvic lymph node dissection Surgery + abdominal aortic lymph node dissection. Results The total effective rate of neoadjuvant chemotherapy was 89.47%. Two groups of age, stage, pathological grade no significant difference (P> 0.05). The amount of bleeding, ambulation time, anal exhaust time and hospital stay in laparoscopic group were less than those in open group. The difference was statistically significant (P <0.05). The number of lymph node dissection, operation time , Incision infection rate comparison, the difference was not statistically significant (P> 0.05). Conclusion Neoadjuvant chemotherapy combined with laparoscopic radical hysterectomy for the treatment of locally advanced cervical cancer is effective, safe and feasible.